In this concise video, gain expert insights on using shared decision-making with patients with IBD who are initiating biologic therapy and learn to effectively discuss data on malignancy risk associated with IBD therapies.
Review best practices of shared-decision making and discussing risk of cancer when discussing initiation of biologic therapy with patients who have IBD.
“Activated” patients with IBD understand their care and have the skills and confidence to manage its intricacies. They also have better outcomes.
Contact Clinical Care Options
For customer support please email: customersupport@cealliance.com
Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191
You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.